Cell Therapy Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Cell Therapy stocks.

Cell Therapy Stocks Recent News

Date Stock Title
May 2 CARM Carisma Therapeutics Inc. (CARM) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
May 2 CARM Carisma Therapeutics names Eugene Kennedy as chief medical officer
May 2 CARM Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical Officer
Apr 30 CERO CERo Therapeutics, Inc. Presents Encouraging Preclinical Data for AML on CER-1236 at Stanford Drug Discovery Symposium Highlighting Tumor Elimination and Manufacturing Attributes
Apr 30 SNTI Senti Bio Announces Publication of SENTI-202 Preclinical Data Demonstrating Potential of Logic-Gated CAR-NK Cell Therapy for the Treatment of Acute Myeloid Leukemia (AML)
Apr 30 LCTX Lineage Receives Grant From California Institute for Regenerative Medicine (CIRM)
Apr 29 LCTX Lineage Cell Therapeutics board chairman passes away
Apr 29 LCTX Lineage Announces Changes to Board of Directors
Apr 29 CGEM Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Apr 29 CGEM Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday
Apr 29 SCPX Scorpius Holdings GAAP EPS of -$1.74
Apr 29 SCPX Scorpius Holdings Provides 2023 Year-End Business Update; Reports 570% Sequential Increase in Revenue for the Fourth Quarter of 2023
Apr 29 NKGN NKGen Biotech Announces FDA Clearance of Investigational New Drug (IND) Application for SNK01 NK Cell Therapy in Parkinson’s Disease
Apr 29 CGEM Cullinan Therapeutics appoints CFO
Apr 29 CGEM Cullinan Therapeutics Announces Appointment of Mary Kay Fenton as Chief Financial Officer
Apr 27 CGEM Amgen’s Blincyto data send Cullinan higher
Apr 26 CGEM Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Cell Therapy

Cell therapy (also called cellular therapy or cytotherapy) is therapy in which cellular material is injected into a patient; this generally means intact, living cells. For example, T cells capable of fighting cancer cells via cell-mediated immunity may be injected in the course of immunotherapy.
Cell therapy originated in the nineteenth century when scientists experimented by injecting animal material in an attempt to prevent and treat illness. Although such attempts produced no positive benefit, further research found in the mid twentieth century that human cells could be used to help prevent the human body rejecting transplanted organs, leading in time to successful bone marrow transplantation.Today two distinct categories of cell therapy are recognized.The first category is cell therapy in mainstream medicine. This is the subject of intense research and the basis of potential therapeutic benefit. Such research can be controversial when it involves human embryonic material.
The second category is in alternative medicine, and perpetuates the practice of injecting animal materials in an attempt to cure disease. This practice, according to the American Cancer Society, is not backed by any medical evidence of effectiveness, and can have deadly consequences.

Browse All Tags